Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilbert Zwart

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
Cancers|January 23, 2024
It Takes Two to Tango: The Interplay between Prostate Cancer and Its Microenvironment from an Epigenetic PerspectiveAnniek Zaalberg, Elisabeth Pottendorfer, Wilbert Zwart, et al.
Nature Reviews. Clinical Oncology|July 22, 2015
Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?Wilbert Zwart, Huub Terra, Sabine C Linn, et al.
Chemistry & Biology|July 29, 2009
Perturbation of estrogen receptor alpha localization with synthetic nona-arginine LXXLL-peptide coactivator binding inhibitorsMaëlle Carraz, Wilbert Zwart, Trang Phan, et al.
Cells|July 2, 2021
TRIMming Down Hormone-Driven Cancers: The Biological Impact of TRIM Proteins on Tumor Development, Progression and PrognosticationEleonora Pauletto, Nils Eickhoff, Nuno A Padrão, et al.
Breast Cancer Research and Treatment|August 6, 2013
Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnosticsFloris H Groenendijk, Wilbert Zwart, Arno Floore, et al.
Molecular Cancer Therapeutics|May 22, 2007
Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor alphaWilbert Zwart, Alexander Griekspoor, Mariska Rondaij, et al.
Nature Communications|November 8, 2019
Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivoYongsoo Kim, Tycho Bismeijer, Wilbert Zwart, et al.
NAR Genomics and Bioinformatics|February 13, 2026
<i>DEprot</i>: a comprehensive R-package for the analysis of label-free quantitation mass spectrometry dataNils Eickhoff, Liesbeth Hoekman, Onno Bleijerveld, et al.
BMC Genomics|April 10, 2013
A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samplesWilbert Zwart, Rutger Koornstra, Jelle Wesseling, et al.
The EMBO Journal|October 18, 2011
Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancerWilbert Zwart, Vasiliki Theodorou, Marleen Kok, et al.
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Cancers|January 23, 2024
It Takes Two to Tango: The Interplay between Prostate Cancer and Its Microenvironment from an Epigenetic PerspectiveAnniek Zaalberg, Elisabeth Pottendorfer, Wilbert Zwart, et al.
Nature Reviews. Clinical Oncology|July 22, 2015
Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?Wilbert Zwart, Huub Terra, Sabine C Linn, et al.
Chemistry & Biology|July 29, 2009
Perturbation of estrogen receptor alpha localization with synthetic nona-arginine LXXLL-peptide coactivator binding inhibitorsMaëlle Carraz, Wilbert Zwart, Trang Phan, et al.
Cells|July 2, 2021
TRIMming Down Hormone-Driven Cancers: The Biological Impact of TRIM Proteins on Tumor Development, Progression and PrognosticationEleonora Pauletto, Nils Eickhoff, Nuno A Padrão, et al.
Breast Cancer Research and Treatment|August 6, 2013
Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnosticsFloris H Groenendijk, Wilbert Zwart, Arno Floore, et al.
Molecular Cancer Therapeutics|May 22, 2007
Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor alphaWilbert Zwart, Alexander Griekspoor, Mariska Rondaij, et al.
Nature Communications|November 8, 2019
Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivoYongsoo Kim, Tycho Bismeijer, Wilbert Zwart, et al.
NAR Genomics and Bioinformatics|February 13, 2026
<i>DEprot</i>: a comprehensive R-package for the analysis of label-free quantitation mass spectrometry dataNils Eickhoff, Liesbeth Hoekman, Onno Bleijerveld, et al.
BMC Genomics|April 10, 2013
A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samplesWilbert Zwart, Rutger Koornstra, Jelle Wesseling, et al.
The EMBO Journal|October 18, 2011
Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancerWilbert Zwart, Vasiliki Theodorou, Marleen Kok, et al.
Pageof 18